You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nasal continuous positive airway pressure (NCPAP)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Food Allergy Trial in Helsinki (Oral immunotherapy)

Active, not recruiting
  • Food Allergy
  • Oral immunotherapy
  • Helsinki, Finland
    Helsinki University Central Hospital
Jul 1, 2022

HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Trastuzumab deruxtecan
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Aug 7, 2023

Surgical Incision, Pain, Postoperative, Pain, Acute Trial in San Diego (Bupivacaine 0.25%, Normal Saline)

Withdrawn
  • Surgical Incision
  • +2 more
  • Bupivacaine 0.25%
  • Normal Saline
  • San Diego, California
    University Of California San Diego
May 24, 2022

Syncope, Vasovagal, Postural Orthostatic Tachycardia Syndrome, Orthostatic Intolerance Trial in Vancouver (Counterpressure

Recruiting
  • Syncope, Vasovagal
  • +2 more
  • Counterpressure Maneuvers
  • Usual Care
  • Vancouver, British Columbia, Canada
    BC Children's Hospital
Nov 10, 2022

Respiratory Failure, Intracranial Hypertension Trial in Chapel Hill (Esophageal Balloon catheter)

Terminated
Has Results
  • Respiratory Failure
  • Intracranial Hypertension
  • Esophageal Balloon catheter
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Apr 6, 2021

Anesthesia Trial in Jerusalem (PMD-200)

Completed
  • Anesthesia
  • PMD-200
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Jan 16, 2022

Low Back Pain Trial in United States (Hydrocodone ER, Placebo)

Completed
Has Results
  • Low Back Pain
  • Hydrocodone ER
  • Placebo
  • Birmingham, Alabama
  • +60 more
Nov 6, 2021

Breast Tumor, Neoadjuvant Therapy, Axillary Lymph Nodes Trial in Netherlands (RISAS)

Completed
  • Breast Neoplasm
  • +3 more
  • RISAS
  • Assen, Netherlands
  • +13 more
Feb 9, 2022

Atomoxetine in the Neuropsychological Tests Among ADHD

Completed
  • Attention Deficit Disorder With Hyperactivity
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 6, 2021

    Urticaria, Chronic Idiopathic Urticaria Trial (desloratadine)

    Completed
    • Urticaria
    • Chronic Idiopathic Urticaria
    • (no location specified)
    Feb 7, 2022

    Endoscopic Ultrasonography-guided Fine Needle Aspiration, Sedation Complication, Remimazolam Trial in Changsha (Remimazolam

    Recruiting
    • Endoscopic Ultrasonography-guided Fine Needle Aspiration
    • +2 more
    • Remimazolam Injection
    • Propofol Injection
    • Changsha, Hunan, China
      The Third Xiangya Hospital of Central South University
    Jun 23, 2022

    MRI - Paraclinical Examination in Sudden Deafness Associated

    Recruiting
    • Vertigo Labyrinthine
      • Strasbourg, France
        Service d'ORL et de Chirurgie Cervico-Faciale - CHU de Strasbour
      Dec 14, 2022

      Diabetes Type 2 Trial in Sydney (Opuz NICGM)

      Completed
      • Diabetes Type 2
      • Opuz NICGM
      • Sydney, New South Wales, Australia
        Scimita Operations
      Jul 15, 2021

      Diabetes, Substance Use Disorders, Anxiety Disorders Trial (Habit Change)

      Not yet recruiting
      • Diabetes
      • +3 more
      • Habit Change
      • (no location specified)
      Nov 1, 2023

      Chronic Kidney Disease Trial in Worldwide (runcaciguat, Placebo)

      Completed
      • Chronic Kidney Disease
      • Innsbruck, Austria
      • +70 more
      May 9, 2022

      Nicotine Dependence Trial in Durham (Varenicline Standard Protocol, Nicotine Patch Standard Protocol, Varenicline Adaptive

      Completed
      Has Results
      • Nicotine Dependence
      • Varenicline Standard Protocol
      • +3 more
      • Durham, North Carolina
        Duke Center for Smoking Cessation
      Aug 17, 2021

      Obesity, Compensated Cirrhosis, Sarcopenia Trial (Continuous Energy Restriction (CER), Alternate Day Modified Fasting (ADMF),

      Not yet recruiting
      • Obesity
      • +2 more
      • Continuous Energy Restriction (CER)
      • +6 more
      • (no location specified)
      May 4, 2022

      Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

      Recruiting
      • Pulmonary Tuberculosis
      • Beijing, Beijing, China
        Beijing Chest Hospital affiliated to Capital Medical University
      Dec 14, 2021

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

      Completed
      Has Results
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 3, 2022

      Intra Cerebral Hypertension, Lactate Sodium Solution Trial (Lactate, Sodium, Hypertonic saline)

      Not yet recruiting
      • Intra Cerebral Hypertension
      • Lactate Sodium Solution
      • Lactate, Sodium
      • Hypertonic saline
      • (no location specified)
      Oct 30, 2023

      Physical Status and Upper Airway Function in Neuromuscular

      Completed
      • Neuromuscular Diseases
      • +2 more
        • Granada, Spain
          University of Granada
        Oct 9, 2020

        Bronchiolitis Obliterans Trial (Exercise group)

        Not yet recruiting
        • Bronchiolitis Obliterans
        • Exercise group
        • (no location specified)
        May 25, 2023

        Platelet Reactivity in Non-cardiac Inflammation A Prospective

        Not yet recruiting
        • Inflammatory Response
        • Platelet Aggregation, Spontaneous
        • No intervention given
        • (no location specified)
        Mar 15, 2023

        Hormone Receptor Positive Breast Cancer Trial in Worldwide (Everolimus, Letrozole, Exemestane)

        Completed
        Has Results
        • Hormone Receptor Positive Breast Cancer
        • Birmingham, Alabama
        • +51 more
        Jan 12, 2022

        Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)

        Withdrawn
        • Asthma
        • SCH 32088 mometasone furoate (MF) metered-dose inhaler
        • Placebo metered-dose inhaler BID
        • (no location specified)
        Feb 7, 2022